Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kei Arai is active.

Publication


Featured researches published by Kei Arai.


Urologic Oncology-seminars and Original Investigations | 2008

Primary solitary fibrous tumor (SFT) in the retroperitoneum

Itsuhiro Takizawa; Toshihiro Saito; Yasuo Kitamura; Kei Arai; Makoto Kawaguchi; Kota Takahashi; Noboru Hara

BACKGROUND Solitary fibrous tumor (SFT) is an infrequent but distinct neoplasm, which generally arises from submesothelial connective tissue in the pleura. SFT is rarely recognized in extrathoracic sites, and histologically identical conditions have also been reported in the retroperitoneum, although their pathophysiology has not been extensively investigated. METHODS We present four cases of primary SFT in the retroperitoneum, and review 37 similar cases in the previous literature. RESULTS About 40% of patients were asymptomatic, and 19.2% and 15.4% presented with an abdominal mass and urinary symptoms, respectively. The tumor size ranged between 2 and 26 (mean 9.1) cm. Sixty-three percent of tumors showed nonspecific development with haphazard distribution of bland short spindle or polygonal cells with or without collagenous bundles and stromal hyalinization. In 22.0%, hemangiopericytomatous appearance was seen. About 15% of cases showed histologically malignant characteristics. The tumor cells were immunoreactive for vimentin in all cases, CD34 in 91% and Bcl-2 in 86%. All tumors were excised, and in 85.4% of cases, tumors did not recur postoperatively for 6 to 48 months. No significant difference was found between the recurrence rate of histologically benign and malignant cases. Cases positive for both CD34 and Bcl-2 had no recurrence. CONCLUSIONS The identification of SFT in the retroperitoneum is of importance because histopathological indicators of malignancy are not necessarily associated with clinical malignant potential in many cases of retroperitoneal SFT. Retroperitoneal SFT showing typical pathological features with expression of CD34 and Bcl-2 is associated with a favorable outcome following excision.


Urological Research | 2000

Expression of m2 muscarinic acetylcholine receptor mRNA in primary culture of human prostate stromal cells.

Kenji Obara; Kei Arai; N. Miyajima; Akihiko Hatano; Yoshihiko Tomita; Kota Takahashi

Abstract The aim of this study was to investigate the expression of the muscarinic acetylcholine receptor (mAchR) subtypes mRNA in primary culture of human prostate stromal cells using the reverse transcription polymerase chain reaction (RT-PCR), RNA blotting and in situ hybridization (ISH). Using an explant method, we obtained a primary culture of prostate stromal cells from three patients with benign prostatic hypertrophy. Total RNA was extracted using the acid guanidinium method for cDNA synthesis. First-strand cDNA was then used for PCR with primers designed to amplify the fragments of each mAchR subtypes (m1–m5) cDNA sequence. The m2, m3 and m4 subtype expected bands were detected; in particular m2 transcripts was strongly detected in the stromal cell culture. Each of the PCR products were subcloned into the pGEM-T plasmid vector, sequenced and random primer labeled using 32P. Digoxigenin-labeled cRNA probes were synthesized by in vitro transcription. RNA blotting using a m2 muscarinic receptor cDNA probe revealed a 4.5 kb single transcript. However, m3 and m4 probes did not hybridize. Using in situ hybridization (ISH), m2 receptor mRNA signals were detected in several smooth muscle cells. The staining was predominantly localized to the perinuclear cytoplasm. The m3 and m4 probes did not hybridize. These results suggested that m2 receptor subtype plays a role in smooth muscle activity of the human prostate.


Gynecologic and Obstetric Investigation | 2010

Growing Teratoma Syndrome of the Ovary after Fertility-Sparing Surgery and Successful Pregnancy

Hiroshi Matsushita; Kei Arai; Masayuki Fukase; Takeshi Takayanagi; Hirokazu Ikarashi

Background: Growing teratoma syndrome (GTS) is rare and is defined as an enlarging mature teratoma that arises during or after chemotherapy for a malignant germ cell tumor, with normalization of previously elevated serum tumor markers. Case: A 30-year-old nulliparous Japanese woman was diagnosed as having a stage IIIa immature teratoma. After fertility-sparing surgery, she received 4 cycles of chemotherapy consisting of cisplatin, etoposide and bleomycin. Thereafter, she successfully gave birth twice. Eight years after the initial surgery, a mass mimicking an adrenal tumor was resected laparoscopically. Surgical specimens revealed a mature teratoma, and she was diagnosed as having GTS postoperatively. Conclusion: Clinicians should consider that GTS may present late, even after pregnancy. Therefore, long-term follow-up of patients treated for ovarian immature teratoma should be mandatory.


European Urology | 1999

α1- and α2-Adrenoceptors in BPH

Masayuki Takeda; Akihiko Hatano; Kei Arai; Kenji Obara; Toshiki Tsutsui; Kota Takahashi

The dynamic obstruction of the bladder outlet secondary to benign prostatic hyperplasia (BPH), and the contractile properties of the human prostate are mediated primarily by α<sub>1</sub>-adrenoceptors. There are now at least three subtypes (A, B, and D) of α<sub>1</sub>-adrenoceptors, and recent work revealed that α<sub>1A</sub>-adrenoceptor and α<sub>1B</sub>-adrenoceptor may have a prime role for prostatic obstruction, and contraction of artery, respectively. Very recently, the presence of a low affinity α<sub>1</sub>-adrenoceptor for prazosin, named α<sub>1L</sub>, in the human BPH tissue has been determined. Because the DNA sequence of α<sub>1L</sub>-adrenoceptor has not yet been cloned, the α<sub>1L</sub>-adrenoceptor may be another form of the α<sub>1A</sub>-adrenoceptor, or another pharmacologically distinct α<sub>1</sub>-adrenoceptor which mediates the norepinephrine-induced contraction of the prostatic smooth muscle. Furthermore, the contribution of α<sub>1</sub>-adrenoceptors in the prostate to symptoms (not only obstructive, but irritative symptoms) which are elicited by prostatic obstruction remains to be determined.


BMC Urology | 2013

Retroperitoneoscopic donor nephrectomy with a gel-sealed hand-assist access device

Kei Arai; Tsutomu Nishiyama; Noboru Hara; Takashi Kasahara; Kazuhide Saito; Kota Takahashi

BackgroundThe hand-assisted technique enables the rapid extraction of the graft, shortening the warm ischemia time (WIT), and the retroperitoneoscopic approach is potentially associated with a less incidence of postoperative ileus in donor nephrectomy for living kidney transplantation. The aim of this study was to assess the efficacy and safety of retroperitoneoscopic donor nephrectomy with a gel-sealed hand-assist access device (GelPort), which is a wound sealing device that permits the access of the hand to the surgical field, free trocar site choice within it, and rapid conversion to open surgery if necessary, while preserving the pneumoperitoneum/pneumoretroperitoneum.MethodsSeventy-five consecutive donors receiving this procedure were retrospectively studied. A 2-cm skin incision was made at the midpoint between the tip of the 12th rib and superior border of the iliac bone in the midaxillary line, through which retroperitoneal space was made. Preperitoneal wound with a 6 – 7-cm pararectal incision in the upper abdominal region was connected to the retroperitoneal space. A GelPort was put inside the pararectal surgical wound. The principle was pure retroperitoneoscopic surgery; hand-assist was applied for retraction of the kidney in the renal vessel control and graft extraction.ResultsThe mean operation time including waiting time for recipient preparation was 242.2±37.0 (range: 214.0–409.0) min, and the mean amount of blood loss was 164.3±146.6 (range: 10.0–1020.0) ml. The mean WIT was 2.8±1.0 (range: 1.0–6.0) min. The shortage of renal vessels or ureter was observed in none of the grafts. No donor experienced blood transfusion, open conversion, or injury of other organs. Blood loss was greater in patients with body mass index (BMI) of 25 kg/m2 or higher than in those with BMI of <25 kg/m2 (218.4±98.8 vs. 154.8±152.1 ml, P=0.031). No donor had postoperative ileus or reported wound pain leading to decreased activity of daily life or wound cosmetic problem.ConclusionsRetroperitoneoscopic hand-assisted donor nephrectomy with the mentioned approach was suggested to be a feasible option without compromising safety, although further improvement in surgical techniques is warranted.


Urological Research | 2001

G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells

Kenji Obara; Kei Arai; Yoshihiko Tomita; Akihiko Hatano; Kota Takahashi

Abstract. The aim of this study was to investigate the expression of G-protein coupled receptor kinases (GRKs) mRNA by RT-PCR and GRKs protein by immunohistochemistry in human detrusor cultured smooth muscle. Primary cultures of human detrusor smooth muscle cells were established using the explant method from three normal bladders. The expression of each GRK, β-adrenergic receptor and muscarinic acethylcholine receptor (mAchR) mRNA was examined by reverse transcription polymerase chain reaction (RT-PCR). Immunohistochemical staining was also performed using primary antibodies for GRKs. The GRK2 and GRK3 transcripts were detected by RT-PCR. The m2, m3 and m5 mAchR and β1, β2 and β3 adrenergic receptor subtypes mRNA were also detected. Using immunohistochemistry, both GRK2 and GRK3 were found to be expressed in detrusor smooth muscle cells. These results demonstrated the existence of GRK2 and GRK3 and the co-expression of m2, m3 and m5 mAchR and β1, β2 and β3 adrenergic receptor subtypes in detrusor smooth muscle cells. The possibility exists that these kinases play a role in the desensitization mechanism of mAchR and β adrenergic receptors.


Gynecologic and Obstetric Investigation | 2010

Contents Vol. 69, 2010

Seiji Mabuchi; Hiromi Ugaki; Fumiaki Isohashi; Yasuo Yoshioka; Kumiko Temma; Namiko Yada-Hashimoto; Takashi Takeda; Toshiya Yamamoto; Kiyoshi Yoshino; Ryuichi Nakajima; Ayman Al-Talib; Togas Tulandi; Mehmet Bardakci; Osman Balci; Ali Acar; Mehmet Cengiz Colakoglu; Hiroshi Matsushita; Kei Arai; Masayuki Fukase; Takeshi Takayanagi; Hirokazu Ikarashi; Grace Kong; Wing Hung Tam; Michael Ho Ming Chan; Wing Yee So; Christopher Wai Kei Lam; Ivy Po Chu Yiu; Kit Man Loo; Chi Yin Li; Mahmoud S. Zakherah

M.A. Belfort, Provo, Utah J. Bornstein, Nahariya H.L. Brown, Durham, N.C. C. Chapron, Paris J. de Haan, Maastricht G.A. Dekker, Adelaide J.A. Deprest, Leuven K. Hecher, Hamburg S. Kahhale, São Paulo H. Kliman, New Haven, Conn. T.F. Kruger, Tygerberg J.A. Kuller, Raleigh, N.C. M.J. Kupferminc, Tel Aviv H. Minkoff , Brooklyn, N.Y. J. Moodley, Congella J.M. Mwenda, Nairobi H. Odendaal, Tygerberg J.T. Repke, Hershey, Pa. Founded 1895 as ‘Monatsschrift für Geburtshilfe und Gynäkologie’, continued 1946–1969 as ‘Gynaecologia’ and 1970–1977 as ‘Gynecologic Investigation’


Journal of Pharmacology and Experimental Therapeutics | 1999

Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods.

Masayuki Takeda; Kenji Obara; Takaki Mizusawa; Yoshihiko Tomita; Kei Arai; Toshiki Tsutsui; Akihiko Hatano; Kota Takahashi; Shintaro Nomura


Clinical Science | 1999

Pharmacological and molecular biological evidence for ETA endothelin receptor subtype mediating mechanical responses in the detrusor smooth muscle of the human urinary bladder.

Takako Okamoto-Koizumi; Masayuki Takeda; Takeshi Komeyama; Akihiko Hatano; Makoto Tamaki; Takaki Mizusawa; Toshiki Tsutsui; Kenji Obara; Yoshihiko Tomita; Kei Arai; Kota Takahashi


Japanese Journal of Pharmacology | 1999

Characterization of the mouse α1D-adrenergic receptor gene

Kei Arai; Akito Tanoue; Nobuhito Goda; Masayuki Takeda; Kota Takahashi; Gozoh Tsujimoto

Collaboration


Dive into the Kei Arai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge